Inventor · disambiguated record
Sanjita Sasmal
Also filed as: SASMAL SANJITA
7 granted patents·7 pending applications·23 citations·filing 2012–2024
78Inventor score
Files withAURIGENE ONCOLOGY LTD3ASTELLAS ENG SMALL MOLECULES US INCORPORATED2AURIGENE DISCOVERY TECH LTD2ORION CORP2BOCK MARK GARY1
Top patents by PatentIndex Score
14 records- 0194US11865114B2Method for treating diseases using SMARCA2/4 degradersAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Jan 9, 2024·5 cites·46 claims
- 0294US10766888B1HMOX1 inducersMITOBRIDGE INC·Filed 2020·Granted Sep 8, 2020·16 cites·11 claims
- 0376US12071433B2HMOX1 inducersASTELLAS ENG SMALL MOLECULES US INCORPORATED·Filed 2023·Granted Aug 27, 2024·0 cites·11 claims
- 0476US2024156814A1Method for Treating Diseases Using SMARCA2/4 DegradersAURIGENE ONCOLOGY LTD·Filed 2024·Application pending·0 cites
- 0574US10077259B2Bicyclic heterocyclic derivatives as bromodomain inhibitorsORION CORP·Filed 2015·Granted Sep 18, 2018·2 cites·11 claims
- 0673US2024409533A1Hmox1 inducersASTELLAS ENG SMALL MOLECULES US INCORPORATED·Filed 2024·Application pending·0 cites
- 0771US2024270734A1Pyridazine Derivatives as SMARCA2/4 DegradersAURIGENE ONCOLOGY LTD·Filed 2024·Application pending·0 cites
- 0859US12371426B2Pyridazine derivatives as SMARCA2/4 degradersAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jul 29, 2025·0 cites·118 claims
- 0958US2025145601A1Novel bicyclic compounds as rad51 inhibitorsSATYA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1056US2024425501A1Novel bicyclic heteroaryl derivatives as sos1:kras proteinprotein interaction inhibitorsSASMAL SANJITA·Filed 2022·Application pending·0 cites
- 1154US2025145609A13-substituted pyridazine compounds as smarca2 and/or smarca4 degradersAURIGENE ONCOLOGY LTD·Filed 2023·Application pending·0 cites
- 1250US10590118B2Bicyclic heterocyclic derivatives as bromodomain inhibitorsORION CORP·Filed 2018·Granted Mar 17, 2020·0 cites·9 claims
- 1341US2015299120A1Spirohydantoin compounds and their use as selective androgen receptor modulatorsNOVARTIS AG·Filed 2013·Application pending·0 cites
- 1440US9051326B2Pyrazoline derivatives and their use as selective androgen receptor modulatorsBOCK MARK GARY·Filed 2012·Granted Jun 9, 2015·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Sanjita Sasmal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →